tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $5.71. This is a potential upside of $5.71 (0%) from yesterday's end of day stock price of $0.
Akcea Therapeutics's activity chart (see below) currently has 23 price targets and 18 ratings on display.
Analysts average stock forecasts to be materialized ratio is 63.75% with an average time for these price targets to be met of 27.25 days.
Most recent stock forecast was given by DO KIM from PIPER SANDLER on 01-Sep-2020. First documented stock forecast 08-Aug-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$30
4 years 3 months 20 days ago
(01-Sep-2020)
2/8 (25%)
$14.76 (96.85%)
30
Hold
$20
$1.83 (10.07%)
$31
4 years 7 months 15 days ago
(06-May-2020)
2/4 (50%)
$0.93 (13.82%)
13
Hold
$24
$5.83 (32.09%)
$33
5 years 2 months 28 days ago
(23-Sep-2019)
4/5 (80%)
$5.96 (33.04%)
39
Hold
6 years 2 months 26 days ago
(25-Sep-2018)
2/2 (100%)
$1.2 (5.04%)
27
What is AKCA (Akcea Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AKCA (Akcea Therapeutics) with a proven track record?
Which analyst has the current lower performing score on AKCA (Akcea Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AKCA (Akcea Therapeutics)?
Which analyst is the currently most bullish on AKCA (Akcea Therapeutics)?
Which analyst is the currently most reserved on AKCA (Akcea Therapeutics)?
